Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

Published 12/05/2023, 13:20
Updated 12/05/2023, 14:40
© Reuters.  Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

© Reuters. Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • Getaround, Inc. (NYSE: GETR) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million.
  • Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 35.2% to $2.61 in pre-market trading after the company highlighted recent corporate progress, and reported financial results for the first quarter.
  • Blue Bird Corporation (NASDAQ: BLBD) shares gained 30% to $25.16 in pre-market trading after the company reported better-than-expected Q2 results.
  • Rubicon Technologies, Inc. (NYSE: RBT) shares rose 19.5% to $0.5340 in pre-market trading after dropping around 15% on Thursday.
  • Momentus Inc. (NASDAQ: MNTS) shares gained 18.5% to $0.4979 in pre-market trading following Q1 results.
  • Babylon Holdings Limited (NYSE: BBLN) shares climbed 16% to $1.38 in pre-market trading after dropping 42% on Thursday. Babylon recently reported mixed Q1 financial results. The company also announced it secured financing and plans to implement a take private transaction with support from AlbaCore Capital.
  • Cidara Therapeutics, Inc. (NASDAQ: CDTX) rose 13.4% to $1.34 in pre-market trading following better-than-expected quarterly sales.
  • Intelligent Bio Solutions Inc. (NASDAQ: INBS) gained 12.5% to $3.39 in pre-market trading after reporting Q3 results.
  • OppFi Inc. (NYSE: OPFI) rose 12.2% to $2.30 in pre-market trading as the company posted upbeat Q1 results and raised FY23 EPS guidance.
  • Ouster, Inc. (NYSE: OUST) gained 11.5% to $4.28 in pre-market trading following strong Q1 sales results.
Losers
  • VirnetX Holding Corporation (NYSE: VHC) fell 19.6% to $0.35 in pre-market after gaining around 15% on Thursday. VirnetX recently announced a partnership with Samsung.
  • Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares dropped 14.7% to $0.6824 in pre-market trading. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
  • VCI Global Limited (NASDAQ: VCIG) fell 11.1% to $3.13 in pre-market trading after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
  • Addex Therapeutics Ltd (NASDAQ: ADXN) shares fell 11% to $0.7915 in pre-market trading. Addex Therapeutics shares dropped around 6% on Thursday after the company reported Q1 financial results.
  • MMTec, Inc. (NASDAQ: MTC) fell 10.7% to $0.9808 in pre-market trading after gaining more than 5% on Thursday.
  • Austin Gold Corp. (NYSE: AUST) fell 10.2% to $1.06 in pre-market trading. Austin Gold reported the results of the 2023 Annual General Meeting.
  • Assure Holdings Corp. (NASDAQ: IONM) fell 9.8% to $1.74 in pre-market trading after jumping 18% on Thursday. Assure Holdings recently reported preliminary first quarter 2023 financial results.
  • Red Cat Holdings, Inc. (NASDAQ: RCAT) fell 9.1% to $1.00 in pre-market trading. Red Cat recently received order for 200 long-range, high-speed drones for Ukrainian deployment.
  • Unique Fabricating, Inc. (NASDAQ: UFAB) fell 8.8% to $0.2418 in pre-market trading after dropping 16% on Thursday.
  • BIOLASE, Inc. (NASDAQ: BIOL) shares dropped 8.3% to $0.22 in pre-market trading after the company posted Q1 results.

Now Read This: Investor Sentiment Declines Further After Dow Drops For Fourth Consecutive Day

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.